E3BP Inhibitors
E3BP inhibitors primarily consist of muscarinic acetylcholine receptor antagonists that target the cholinergic signaling pathway. Aclidinium bromide, tiotropium bromide, glycopyrrolate, darifenacin, atropine, biperiden, ipratropium bromide, oxybutynin, solifenacin succinate, tropicamide, benztropine mesylate, and pirenzepine belong to this class, all influencing E3BP indirectly. The cholinergic signaling pathway, predominantly mediated by acetylcholine, plays a vital role in cellular responses and downstream signaling cascades. Muscarinic acetylcholine receptor antagonists, such as those listed above, interfere with cholinergic transmission, potentially influencing E3BP by disrupting the normal cellular responses regulated by acetylcholine.
These inhibitors, including Aclidinium bromide and Tiotropium bromide, bind to muscarinic receptors, preventing acetylcholine from binding and activating downstream signaling events. By doing so, they modulate the cholinergic signaling pathway, indirectly impacting E3BP. This modulation can affect cellular processes associated with E3BP function, providing insights into potential regulatory mechanisms. In summary, E3BP inhibitors, represented by muscarinic acetylcholine receptor antagonists, present a pharmacological approach to influence E3BP indirectly through the cholinergic signaling pathway. Understanding the intricacies of this interaction provides a foundation for further exploration of E3BP regulation and its cellular implications.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aclidinium Bromide | 320345-99-1 | sc-480200 | 100 mg | $388.00 | ||
Muscarinic acetylcholine receptor antagonist impacting the cholinergic signaling pathway. Aclidinium bromide modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $200.00 | 2 | |
Non-selective muscarinic acetylcholine receptor antagonist impacting the cholinergic signaling pathway. Atropine modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||
Ipratropium bromide | 22254-24-6 | sc-203606 | 100 mg | $83.00 | 3 | |
Muscarinic acetylcholine receptor antagonist impacting the cholinergic signaling pathway. Ipratropium bromide modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||
Oxybutynin | 5633-20-5 | sc-489869 | 1 g | $135.00 | ||
Muscarinic acetylcholine receptor antagonist affecting the cholinergic signaling pathway. Oxybutynin modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||
Tropicamide | 1508-75-4 | sc-202371 | 100 mg | $31.00 | 3 | |
Muscarinic acetylcholine receptor antagonist affecting the cholinergic signaling pathway. Tropicamide modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||
Benztropine mesylate | 132-17-2 | sc-202495 sc-202495A | 1 g 5 g | $45.00 $157.00 | 3 | |
Muscarinic acetylcholine receptor antagonist impacting the cholinergic signaling pathway. Benztropine mesylate modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||
Pirenzepine Dihydrochloride | 29868-97-1 | sc-204197 | 100 mg | $69.00 | 3 | |
Muscarinic acetylcholine receptor antagonist affecting the cholinergic signaling pathway. Pirenzepine modulates cholinergic transmission, potentially influencing E3BP indirectly by disrupting acetylcholine-mediated cellular responses and downstream signaling cascades. | ||||||